María Laura Ruiz

Dr. María Laura Ruiz

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Juan Pablo RigalliJuan Pablo Rigalli
Juan Pablo Rigalli
NCNadia Ciriaci
Nadia Ciriaci
AAAgostina Arias
Agostina Arias
MCMaría Paula Ceballos
María Paula Ceballos
SVSilvina Stella Maris Villanueva
Silvina Stella Maris Villanueva
MRMaría Laura Ruiz
María Laura Ruiz
Hepatocellular carcinoma (HCC) is the fifth most frequent cancer worldwide. Sorafenib is the only drug available that improves the overall survival of HCC patients. P-glycoprotein (P-gp), Multidrug resistance-associated proteins 2 and 3 (MRP2 and 3) and Breast cancer resistance protein (BCRP) are efflux pumps that play a key role in cancer chemoresistance. Their modulation by dietary compounds may affect the intracellular accumulation and therapeutic efficacy of drugs that are substrates of these transporters. Genistein (GNT) is a phytoestrogen abundant in soybean that exerts its genomic effects through Estrogen-Receptors and Pregnane-X-Receptor (PXR), which are involved in the regulation of the above-mentioned transporters. We evaluated the effect of GNT on the expression and activity of P-gp, MRP2, MRP3 and BCRP in HCC-derived HepG2 cells. GNT (at 1.0 and 10 μM) increased P-gp and MRP2 protein expression and activity, correlating well with an increased resistance to sorafenib cytotoxicity as detected by the methylthiazole tetrazolium (MTT) assay. GNT induced P-gp and MRP2 mRNA expression at 10 but not at 1.0 μM concentration suggesting a different pattern of regulation depending on the concentration. Induction of both transporters by 1.0 μM GNT was prevented by cycloheximide, suggesting translational regulation. Downregulation of expression of the miR-379 by GNT could be associated with translational regulation of MRP2. Silencing of PXR abolished P-gp induction by GNT (at 1.0 and 10 μM) and MRP2 induction by GNT (only at 10 μM), suggesting partial mediation of GNT effects by PXR. Taken together, the data suggest the possibility of nutrient-drug interactions leading to enhanced chemoresistance in HCC when GNT is ingested with soy rich diets or dietary supplements.

18 March 2020 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
MSM. Semeniuk
M. Semeniuk
LCL. I. Ceré
L. I. Ceré
NCN. Ciriaci
N. Ciriaci
MBMaría Bucci-Muñoz
María Bucci-Muñoz
Silvina Stella Maris VillanuevaSilvina Stella Maris Villanueva
Silvina Stella Maris Villanueva
MRMaría Laura Ruiz
María Laura Ruiz

1 September 2015 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
MAMaite Arana
Maite Arana
GTGuillermo Nicolás Tocchetti
Guillermo Nicolás Tocchetti
PDPablo Domizi
Pablo Domizi
AAAgostina Arias
Agostina Arias
Juan Pablo RigalliJuan Pablo Rigalli
Juan Pablo Rigalli
SVSilvina Stella Maris Villanueva
Silvina Stella Maris Villanueva

1 August 2013 in Biochemical Pharmacology
Verified
Journal Article
Open access
MRMaría Laura Ruiz
María Laura Ruiz
Juan Pablo RigalliJuan Pablo Rigalli
Juan Pablo Rigalli
AAAgostina Arias
Agostina Arias
SVSilvina Stella Maris Villanueva
Silvina Stella Maris Villanueva
CBClaudia Banchio
Claudia Banchio
VCViviana Alicia Catania
Viviana Alicia Catania
Previously, we have demonstrated that 17α-ethynylestradiol (EE) induces rat multidrug-resistance associated protein 3 (Mrp3, Abcc3) expression transcriptionally through estrogen receptor-α (ER-α) activation. We explored the effect of EE on MRP3 expression of human origin. HepG2 cells were transfected with ER-α and incubated with EE (1-10-50 μM) for 48 h. MRP3 protein and mRNA levels were measured by Western blotting and Real time PCR, respectively. EE up-regulated MRP3 protein and mRNA at 50 μM only in ER-α(+)-HepG2 cells. The in silico analysis of mrp3 promoter region demonstrated absence of estrogen response elements, but showed several Ap-1 binding sites. We further evaluated the potential involvement of the transcription factors c-JUN and c-FOS (members of Ap-1) in MRP3 up-regulation. ER-α(+) HepG2 cells were incubated with EE and c-FOS and c-JUN levels measured by Western blotting in nuclear extracts. EE up-regulated only c-JUN. Experiments of overexpression and knock-down of c-JUN by siRNA further demonstrated that this transcription factor is indeed implicated in MRP3 upregulation by EE. Co-immunoprecipitation assay demonstrated that EE induces c-JUN/ER-α interaction, and chromatin immunoprecipitation assay showed that this complex is recruited to the AP-1 binding consensus element present at the position (-1300/-1078 bp) of human mrp3 promoter. We conclude that EE induces MRP3 expression through ER-α, with recruitment of ER-α in complex with c-JUN to the human mrp3 promoter.

1 November 2009 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MRMaría Laura Ruiz
María Laura Ruiz
Silvina Stella Maris VillanuevaSilvina Stella Maris Villanueva
Silvina Stella Maris Villanueva
MLMarcelo G. Luquita
Marcelo G. Luquita
JPJosé M. Pellegrino
José M. Pellegrino
Juan Pablo RigalliJuan Pablo Rigalli
Juan Pablo Rigalli
VCViviana A. Catania
Viviana A. Catania

25 September 2024 in Biochemical Pharmacology
Verified
Journal Article
Closed access
AGAldana Magalí Gola
Aldana Magalí Gola
MBMaría Bucci-Muñoz
María Bucci-Muñoz
JRJuan Pablo Rigalli
Juan Pablo Rigalli
MCMaría Paula Ceballos
María Paula Ceballos
MRMaría Laura Ruiz
María Laura Ruiz